Drugs / THERATOPE®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00046371 | Aug 2002 → Aug 2005 | breast neoplasm | Oncothyreon Canada Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | THERATOPE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00046371 ↗ |
| Modality | Vaccine | “THERATOPE® vaccine” NCT00046371 ↗ |